Profusa Completes Business Merger and Nasdaq Trading Launch

Profusa Completes Business Combination

Profusa, Inc. is thrilled to announce a significant evolution in its journey as a digital health company. Following the closing of its business combination with NorthView Acquisition Corp. (NVAC), Profusa is stepping onto the Nasdaq platform, opening new doors for its innovative health technology.

Trading on Nasdaq

Beginning on the anticipated trading date, Profusa's common stock will officially trade under the ticker symbol "PFSA". This milestone represents a leap forward for the company, as it consolidates its position in the competitive digital health landscape.

What's Next for Profusa?

Profusa's vision has always been to utilize science and technology to improve the quality of life and manage chronic health conditions effectively. They have pioneered the development of tissue-integrating biosensors that are not only cost-effective but also capable of continuous biochemical monitoring. This cutting-edge approach empowers patients and healthcare providers with vital health data.

CEO's Vision

Ben Hwang, Ph.D., the company's Chairman and CEO, expressed his excitement: "This journey started over ten years ago, and today we reach a significant milestone by becoming a public company. We believe this status will allow us to escalate our goals in delivering transformative health solutions worldwide." His confidence underscores the potential impact of Profusa's technology in chronic disease management.

Funding for Future Growth

As part of the business combination, Profusa has successfully issued a secured convertible promissory note to an institutional investor, garnering $9 million. These funds will cover transaction costs while supporting the company’s ongoing development and operational requirements, with an option for a total of $20 million.

Advisors Supporting the Transition

Various reputable firms played crucial roles as advisors during this transition. A.G.P./Alliance Global Partners, I-Bankers Securities, and Dawson James Securities provided financial guidance, while Ellenoff Grossman & Schole LLP, ArentFox Schiff LLP, and Lucosky Brookman LLP were instrumental in legal matters.

About Profusa

Headquartered in a vibrant community, Profusa is committed to revolutionizing health monitoring through its innovative biosensor technology. Their products are designed to deliver reliable, real-time health data that clinicians can trust, promoting personalized healthcare experiences.

Innovations in Health Technology

With forward-thinking solutions like its injectable biosensors, Profusa aims to create a consistent health monitoring routine for patients with chronic conditions. The integration of AI and data analytics ensures that this health data is actionable, promoting better decision-making for both users and health professionals.

Frequently Asked Questions

What is Profusa's primary business focus?

Profusa specializes in developing tissue-integrated biosensors for continuous health monitoring, aimed at improving chronic disease management.

When will Profusa begin trading on Nasdaq?

Profusa's common stock is expected to start trading on Nasdaq under the ticker "PFSA" soon after the completion of its business combination.

How much capital did Profusa raise from the convertible note?

Profusa secured $9 million initially with an option for up to $20 million through a convertible promissory note.

Who are the key advisors for Profusa's business combination?

A.G.P./Alliance Global Partners, I-Bankers Securities, and Dawson James Securities acted as financial advisors, among other legal and financial advisors.

What technology does Profusa utilize for health monitoring?

Profusa employs advanced tissue-integrating sensors designed to transmit actionable health data continuously, prioritizing user-friendly applications and AI-driven insights.

About The Author

Hello, my name is Ryan Hughes. I am a financial, economics, and stock market specialist committed to assisting people in negotiating the intricacies of the financial system. Having a great deal of experience and a thorough grasp of market dynamics and economic trends, my area of expertise is converting complex financial ideas into understandable, practical knowledge. By use of my articles and blog entries, I hope to give you the information and assurance you need to make wise financial choices.

I've had the honor of interacting with a wide range of readers as a writer for several financial blogs, from new investors to seasoned market participants. To enable you to reach your financial goals, I want to make finance, economics, and stock market trends understandable and approachable. I appreciate you traveling with me toward success and financial literacy.

Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.